Nsclcpalliativechemo

由 T Beinert 著作 · 1999 — chemotherapy [3, 4]. Furthermore, quality of life was signif- icantly enhanced in those patients, demonstrating a clear bene- fit of chemotherapy in NSCLC [3, 5] ...

由 CB Simone II 著作 · 2013 · 被引用 51 次 — First-line therapy for advanced or recurrent NSCLC should consist of chemotherapy alone or in combination with bevacizumab in patients with good performance ...

由 A Nelson 著作 · 2024 · 被引用 8 次 — This study aimed to understand how palliative chemotherapy treatment decisions are determined and what intervention could support Patients with NSCLC and ...

由 JS Temel 著作 · 2010 · 被引用 8345 次 — Patients with metastatic non–small-cell lung cancer have a substantial symptom burden and may receive aggressive care at the end of life.

由 C von Plessen 著作 · 2006 · 被引用 212 次 — Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.

2024年1月18日 — Palliative chemotherapy. Your doctor may prescribe chemotherapy to shrink your cancer, which may lessen pain and other symptoms. Palliative ...

由 B Ferrell 著作 · 2011 · 被引用 120 次 — Palliative chemotherapy means chemotherapy given primarily for rapid relief of symptoms, not non-curative chemotherapy. Dyspnea related to pulmonary parenchymal ...

由 H Li 著作 · 2016 · 被引用 16 次 — Tumour-directed palliative treatment options for NSCLC include palliative chemotherapy and radiotherapy. For locally advanced unresectable ...

Palliative systemic therapy for advanced non-small-cell lung cancer (NSCLC) including chemotherapy and targeted therapy may improve symptoms related to cancer ...

由 H Bischoff 著作 · 2005 — A randomized phase III trial comparing bexarotene/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or ...